EZH2 and tuberculosis: Oral administration of Bacteroides fragilis promoted anti-TB immunity by increasing long non-coding RNA, lncRNA-CGB expression via the gut bacteria-lncRNA-EZH2-H3K27Me3 axis (Yang et al., 2022).